Sijo Asokan , Teena Jacob , Tijo Cherian , Teena Merlin , Vivekanandhan S , Afaf A AlSosowaa , Mostafa Mohammed Atiyah , Faheem Q Al-Mojahid , Willie J.G.M. Peijnenburg , Smitha Vijayan
{"title":"木瓜内生解淀粉芽孢杆菌NWR-14的HR-LCMS分析、体外和计算机评价","authors":"Sijo Asokan , Teena Jacob , Tijo Cherian , Teena Merlin , Vivekanandhan S , Afaf A AlSosowaa , Mostafa Mohammed Atiyah , Faheem Q Al-Mojahid , Willie J.G.M. Peijnenburg , Smitha Vijayan","doi":"10.1016/j.phyplu.2025.100885","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The rise of multidrug-resistant (MDR) pathogens such as <em>Klebsiella pneumoniae</em>, particularly those producing extended-spectrum β-lactamases (ESBL), has intensified the search for novel bioactive compounds. Medicinal plants, including <em>Piper chaba</em>, host endophytic bacteria that may serve as promising sources of antimicrobial agents.</div></div><div><h3>Purpose</h3><div>This study aimed to evaluate the antibacterial, antibiofilm, antioxidant, and cytotoxic properties of secondary metabolites derived from <em>Bacillus amyloliquefaciens</em> NWR-14, an endophyte isolated from <em>P. chaba</em>, with a focus on its activity against ESBL-producing <em>K. pneumoniae</em>.</div></div><div><h3>Methods</h3><div><em>B. amyloliquefaciens</em> NWR-14 was isolated and identified via 16S rRNA gene sequencing. The ethyl acetate extract of this isolate was tested for antibacterial activity using MIC and MBC assays. Antibiofilm potential was assessed using crystal violet staining. Scanning electron microscopy (SEM) was employed to visualize morphological changes in <em>K. pneumoniae</em>. HR-LCMS was used to putatively annotate bioactive compounds. <em>In silico</em> molecular docking was conducted to assess binding affinities to the CTX-M-15 β-lactamase enzyme. Antioxidant activity was evaluated using DPPH, FRAP, and ABTS assays, and cytotoxicity was tested on fibroblast cells.</div></div><div><h3>Results</h3><div>The extract exhibited notable antibacterial activity with a MIC and MBC of 1.56 mg/mL, and showed dose-dependent biofilm inhibition, achieving maximum effect at 6 mg/mL. SEM analysis confirmed significant cellular damage in <em>K. pneumoniae</em>. HR-LCMS analysis putatively annotated 76 compounds, including alkaloids, saponins, and phenolic acids. Molecular docking revealed strong binding affinities of compounds such as 8′-Hydroxydihydroergotamine and Licoricesaponin E2 to CTX-M-15. The extract demonstrated moderate antioxidant activity and low cytotoxicity, with over 97% cell viability in fibroblast assays.</div></div><div><h3>Conclusions</h3><div><em>B. amyloliquefaciens</em> NWR-14 shows promise as a source of bioactive secondary metabolites with antibacterial, antibiofilm, and antioxidant properties. These findings underscore the potential of endophytic bacteria from medicinal plants as reservoirs of compounds for addressing antimicrobial resistance. Further purification and structural validation of active constituents are recommended to enhance therapeutic applicability.</div></div>","PeriodicalId":34599,"journal":{"name":"Phytomedicine Plus","volume":"5 4","pages":"Article 100885"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"HR-LCMS profiling, in vitro and in silico assessment of the antibacterial activities of endophytic Bacillus amyloliquefaciens NWR-14 from Piper chaba W. Hunter\",\"authors\":\"Sijo Asokan , Teena Jacob , Tijo Cherian , Teena Merlin , Vivekanandhan S , Afaf A AlSosowaa , Mostafa Mohammed Atiyah , Faheem Q Al-Mojahid , Willie J.G.M. Peijnenburg , Smitha Vijayan\",\"doi\":\"10.1016/j.phyplu.2025.100885\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The rise of multidrug-resistant (MDR) pathogens such as <em>Klebsiella pneumoniae</em>, particularly those producing extended-spectrum β-lactamases (ESBL), has intensified the search for novel bioactive compounds. Medicinal plants, including <em>Piper chaba</em>, host endophytic bacteria that may serve as promising sources of antimicrobial agents.</div></div><div><h3>Purpose</h3><div>This study aimed to evaluate the antibacterial, antibiofilm, antioxidant, and cytotoxic properties of secondary metabolites derived from <em>Bacillus amyloliquefaciens</em> NWR-14, an endophyte isolated from <em>P. chaba</em>, with a focus on its activity against ESBL-producing <em>K. pneumoniae</em>.</div></div><div><h3>Methods</h3><div><em>B. amyloliquefaciens</em> NWR-14 was isolated and identified via 16S rRNA gene sequencing. The ethyl acetate extract of this isolate was tested for antibacterial activity using MIC and MBC assays. Antibiofilm potential was assessed using crystal violet staining. Scanning electron microscopy (SEM) was employed to visualize morphological changes in <em>K. pneumoniae</em>. HR-LCMS was used to putatively annotate bioactive compounds. <em>In silico</em> molecular docking was conducted to assess binding affinities to the CTX-M-15 β-lactamase enzyme. Antioxidant activity was evaluated using DPPH, FRAP, and ABTS assays, and cytotoxicity was tested on fibroblast cells.</div></div><div><h3>Results</h3><div>The extract exhibited notable antibacterial activity with a MIC and MBC of 1.56 mg/mL, and showed dose-dependent biofilm inhibition, achieving maximum effect at 6 mg/mL. SEM analysis confirmed significant cellular damage in <em>K. pneumoniae</em>. HR-LCMS analysis putatively annotated 76 compounds, including alkaloids, saponins, and phenolic acids. Molecular docking revealed strong binding affinities of compounds such as 8′-Hydroxydihydroergotamine and Licoricesaponin E2 to CTX-M-15. The extract demonstrated moderate antioxidant activity and low cytotoxicity, with over 97% cell viability in fibroblast assays.</div></div><div><h3>Conclusions</h3><div><em>B. amyloliquefaciens</em> NWR-14 shows promise as a source of bioactive secondary metabolites with antibacterial, antibiofilm, and antioxidant properties. These findings underscore the potential of endophytic bacteria from medicinal plants as reservoirs of compounds for addressing antimicrobial resistance. Further purification and structural validation of active constituents are recommended to enhance therapeutic applicability.</div></div>\",\"PeriodicalId\":34599,\"journal\":{\"name\":\"Phytomedicine Plus\",\"volume\":\"5 4\",\"pages\":\"Article 100885\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phytomedicine Plus\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667031325001563\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytomedicine Plus","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667031325001563","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
HR-LCMS profiling, in vitro and in silico assessment of the antibacterial activities of endophytic Bacillus amyloliquefaciens NWR-14 from Piper chaba W. Hunter
Background
The rise of multidrug-resistant (MDR) pathogens such as Klebsiella pneumoniae, particularly those producing extended-spectrum β-lactamases (ESBL), has intensified the search for novel bioactive compounds. Medicinal plants, including Piper chaba, host endophytic bacteria that may serve as promising sources of antimicrobial agents.
Purpose
This study aimed to evaluate the antibacterial, antibiofilm, antioxidant, and cytotoxic properties of secondary metabolites derived from Bacillus amyloliquefaciens NWR-14, an endophyte isolated from P. chaba, with a focus on its activity against ESBL-producing K. pneumoniae.
Methods
B. amyloliquefaciens NWR-14 was isolated and identified via 16S rRNA gene sequencing. The ethyl acetate extract of this isolate was tested for antibacterial activity using MIC and MBC assays. Antibiofilm potential was assessed using crystal violet staining. Scanning electron microscopy (SEM) was employed to visualize morphological changes in K. pneumoniae. HR-LCMS was used to putatively annotate bioactive compounds. In silico molecular docking was conducted to assess binding affinities to the CTX-M-15 β-lactamase enzyme. Antioxidant activity was evaluated using DPPH, FRAP, and ABTS assays, and cytotoxicity was tested on fibroblast cells.
Results
The extract exhibited notable antibacterial activity with a MIC and MBC of 1.56 mg/mL, and showed dose-dependent biofilm inhibition, achieving maximum effect at 6 mg/mL. SEM analysis confirmed significant cellular damage in K. pneumoniae. HR-LCMS analysis putatively annotated 76 compounds, including alkaloids, saponins, and phenolic acids. Molecular docking revealed strong binding affinities of compounds such as 8′-Hydroxydihydroergotamine and Licoricesaponin E2 to CTX-M-15. The extract demonstrated moderate antioxidant activity and low cytotoxicity, with over 97% cell viability in fibroblast assays.
Conclusions
B. amyloliquefaciens NWR-14 shows promise as a source of bioactive secondary metabolites with antibacterial, antibiofilm, and antioxidant properties. These findings underscore the potential of endophytic bacteria from medicinal plants as reservoirs of compounds for addressing antimicrobial resistance. Further purification and structural validation of active constituents are recommended to enhance therapeutic applicability.